CYBERDYNE Inc.

Equities

7779

JP3311530004

Healthcare Facilities & Services

Delayed Japan Exchange Other stock markets 08:41:21 2024-04-23 pm EDT			5-day change	1st Jan Change
208 ^JPY	-1.42%		+4.00%	-7.14%

Feb. 15	CYBERDYNE Inc. Signs Business Consignment Agreement with New Energy and Industrial Technology Development Organization	CI
2023	Cyberdyne Foresees Potential Bad Debt Loss Amid OCT's Bankruptcy Proceedings	MT

Rehab for JAPAN Co., Ltd. announced that it has received ¥700 million in funding from a group of investors

May 23, 2021

Rehab for JAPAN Co., Ltd announced that it has received ¥700 million in a round of funding on May 24, 2021. The transaction will include participation from new investors CYBERDYNE Inc. (TSE:7779), CEJ Capital Co., Ltd., MTG Ventures Co., Ltd., Mitsubishi UFJ Capital Co., Ltd., Ono Pharmaceutical Co., Ltd. (TSE:4528), KIRIN - GB Investment Limited Partnership, a fund managed by Global Brain Co., Ltd., CVC operated by Toyoshima, returning investors, Capital Medica Ventures Co., Ltd. and SMBC Venture Capital Co., Ltd. The company has raised ¥1.1 billion in funding till date.

Latest news about CYBERDYNE Inc.

CYBERDYNE Inc. Signs Business Consignment Agreement with New Energy and Industrial Technology Development Organization	Feb. 14	CI
Cyberdyne Foresees Potential Bad Debt Loss Amid OCT's Bankruptcy Proceedings	Dec. 29	MT
Cyberdyne to Sign a Consignment Agreement with NEDO; Expects 332 Million Yen in Other Income for Fiscal 2023	Dec. 06	MT
Cyeberdyne Appoints Shinji Honda as New Executive Director and COO	Dec. 05	MT
CYBERDYNE Inc. Appoints Shinji Honda as New Executive Director and Chief Operating Officer, Effective December 18, 2023	Dec. 03	CI
Cyberdyne Books 660 million Yen in Impairment Loss in Fiscal Q2	Nov. 15	MT
Cyberdyne Secures Grant for Development of Robotic Care Device Overseas	23-08-09	MT
Certain Common Stock of Cyfuse Biomedical K.K. are subject to a Lock-Up Agreement Ending on 1-JUN-2023.	23-05-31	CI
CYBERDYNE Inc. Reports Earnings Results for the Full Year Ended March 31, 2023	23-05-15	CI
CYBERDYNE Inc. completed the acquisition of 8% stake in LeyLine GmbH from Midori Moriwaki.	23-03-30	CI
Cyberdyne to Take Controlling Stake in German Racing Team Operator	23-03-30	MT
CYBERDYNE Inc. signed an agreement to acquire 8% stake in LeyLine GmbH from Midori Moriwaki.	23-03-28	CI
Certain Common Stock of Cyfuse Biomedical K.K. are subject to a Lock-Up Agreement Ending on 28-FEB-2023.	23-02-27	CI
Cyberdyne Repurchases 1.2 Billion Yen Worth of Stock; Shares Gain 4%	23-02-21	MT
Tranche Update on CYBERDYNE Inc.'s Equity Buyback Plan announced on February 20, 2023.	23-02-20	CI
CYBERDYNE Inc.'s Equity Buyback announced on February 20, 2023, has closed with 4,000,000 shares, representing 1.86% for ¥1,188 million.	23-02-20	CI
CYBERDYNE Inc. announces an Equity Buyback for 4,000,000 shares, representing 2.91% for ¥1,188 million.	23-02-20	CI
CYBERDYNE Inc. authorizes a Buyback Plan.	23-02-19	CI
Cyberdyne Inc. Announces Yuzo Toda Passed Away on December 27, 2022, and Retired from the Position of Director on the Same Day	23-01-06	CI
Cyfuse Biomedical K.K. has completed an IPO in the amount of Ã‘2.477466 billion.	22-12-01	CI
Cyfuse Biomedical K.K. has filed an IPO.	22-10-27	CI
Hirosaki Lifescience Innovation, Inc. announced that it has received funding from CYBERDYNE Inc.	22-08-16	CI
Xenoma, Inc. announced that it has received funding from CYBERDYNE Inc.	22-08-09	CI
Metcela Inc. announced that it has received ¥1.87 billion in funding from CYBERDYNE Inc., CEJ Capital Co., Ltd., Japan Lifeline Co., Ltd., Sony Ventures Corporation, Reazon Holdings, Inc.	22-06-27	CI
Cyberdyne to Set Up Malaysian Subsidiary	21-12-22	MT

Chart CYBERDYNE Inc.

Duration

Period

More charts

Company Profile

Cyberdyne Inc is engaged in the research, development, manufacture, sale, and maintenance management related to Cybernics technology. The Company mainly uses human and the Internet of Things (IoH/IoT), robots, and artificial intelligence (AI) Cybernics technology to develop Cybernic systems. It develops the Cybernics treatment service business and the training service business that utilize Cybernics technology. The Company develops in various fields centered on HAL. HAL is a robot treatment device for the purpose of improving and regenerating the physical function of patients, a welfare device and life support device for the purpose of supporting independence, and a work support equipment. It can be used for various purposes by being worn and used by people. The Company is also involved in the productization of AI-equipped transport robots; cleaning robots; Cyin, which is used for communication with people with disabilities, and electrocardiography devices.

Sector

Healthcare Facilities & Services

Calendar

2024-05-14 - Q4 2023 Earnings Release

More about the company

Income Statement Evolution

More financial data

Ratings for CYBERDYNE Inc.

Trading Rating

Investor Rating

ESG Refinitiv

D+

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

211 JPY

Average target price

320 JPY

Spread / Average Target

+51.66%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Healthcare Facilities & Services

	1st Jan change	Capi.
CYBERDYNE INC.	-7.14%	276M
CVS HEALTH CORPORATION	-13.25%	87.77B
HCA HEALTHCARE, INC.	+18.01%	82.08B
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY	+11.97%	30.03B
LABORATORY CORPORATION OF AMERICA HOLDINGS	-8.50%	17.08B
FRESENIUS SE & CO. KGAA	-1.46%	16.41B
EUROFINS SCIENTIFIC SE	+4.44%	12.37B
FRESENIUS MEDICAL CARE AG	+5.11%	12.17B
PURE HEALTH HOLDING	-31.05%	11.89B
DAVITA INC.	+27.83%	11.62B

Other Healthcare Facilities & Services